Treatment of central retinal artery occlusions
|
|
- Nora King
- 6 years ago
- Views:
Transcription
1 Treatment of central retinal artery occlusions Jeffrey N. Weiss Retina Associates of South Florida, Margate, Florida, USA To the Editor: As a practicing retinal specialist for the last 28 years, I read the guidelines for the treatment of central retinal artery occlusion (CRAO)(1) with interest. There are two major issues of concern: diagnosis and cause. Making the correct ophthalmic diagnosis Acute visual loss is when the known duration of visual loss is short, to be distinguished from when the patient accidentally discovers a longer-standing visual loss. The elderly patient (the group most affected by CRAO), is frequently unaware of the loss of vision in one eye, until they happen to close the other eye (i.e., a foreign body in the good eye). They date the loss of vision to the time they closed the eye with better vision. The patient is then seen as an emergency with acute visual loss, but retinal examination reveals the visual loss to be long-standing. The acuteness or chronicity of visual loss may be difficult to assess without ophthalmic examination experience. It may also be difficult to perform a retinal examination through a miotic, undilated pupil in an elderly patient with cataracts in the emergency room setting. Many conditions associated with visual loss also exhibit cotton-wool spots (soft exudates) which may be mistaken for the retinal edema seen in arteriolar occlusion. The differential diagnosis includes: pre-proliferative diabetic retinopathy with macular edema; epimacular membrane and vitreomacular traction (the whitish posterior pole sheen may simulate retinal edema); shallow retinal detachment; retinoschisis (a splitting of the retina) extending into the posterior pole; commotio retinae (caused by an ocular contusion); Purtscher s retinopathy (from a crush injury), malignant hypertension, collagen diseases, hematologic conditions, Hodgkin s disease, infective conditions, etc. These diagnoses are sometimes difficult to make, in the best of circumstances, more so in a busy emergency room. The most common cause of visual loss in younger patients is diabetic retinopathy, and in the elderly it is age-related macular degeneration. Vascular occlusion, whether branch retinal vein or artery occlusion, or central retinal vein or artery occlusion, is far less common. CRAO is an infrequent cause of visual loss, occurring in only 0.85 per 100,000 persons per year. (2) Not surprisingly, the EAGLE Study (3), a 16-center randomized controlled prospective trial comparing two treatments for CRAO, has enrolled only 47 patients with CRAO in three years. Determining the cause of the CRAO. Two causes of CRAO, giant cell arteritis and emboli from carotid artery stenosis, may result in further morbidity and even death. While treating visual loss in one eye is important, it should not be at the risk of severe visual loss in the other eye (as in giant cell arteritis) or cerebral stroke (as in emboli from significant carotid stenosis). The risk versus benefits of the treatment of one eye must be put in the perspective of the patient s life. Giant cell arteritis This most common primary vasculitis of adults in the Western world is an immunopathogenic process that results in luminal occlusion as well as a generalized inflammatory response. Three common clinical subtypes have been defined: a systemic inflammatory syndrome, which may include myalgias, weight loss, night sweats and fever of unknown origin; a cranial arteritis including visual loss; and a large-vessel vasculitis, which may include aortic rupture, aortic dissection and death (4,5,6). 51
2 Retinal embolism and risk of stroke Pfaffenbach et al. (7) reported a case-series of 208 patients with retinal emboli. Fifteen percent of this group died within one year, and 54% died within seven years. Cerebral strokes or transient ischemic attacks were present in 63% before or at the time of baseline examination. Bruno et al. (8) studied the risk of stroke in 70 patients with retinal emboli as compared to a 70-person control group. With a 3.4-year follow-up, there was a tenfold increase in the annual stroke rate (8.5% versus 0.8% per year in cases versus controls, p = 0.002). (This may actually represent an underestimation of the stroke risk, as patients with retinal emboli and other additional cardiovascular risk factors, i.e., hypertension and cigarette smoking, may be more likely to die.) The patient presenting to the emergency room with truly acute visual loss may be placed on supplemental oxygen prior to ophthalmology consultation. While a negative result (no visual improvement) is not diagnostic, a positive result (visual improvement) may serve as a provocative test that HBO 2 may be beneficial. Following the examination, the ophthalmologist will refer the patient for HBO 2, if appropriate. While the visual results may not be as good as if the patient had been immediately placed in a hyperbaric chamber, the potential benefit does not justify the risk. The UHMS has recently contacted other specialty societies, including the American Academy of Ophthalmology and the American Society of Retina Specialists, to inform them of the CRAO indication for HBO 2 This opportunity specialists of one society treating the patients of another must be tempered with the natural human tendency and appropriateness of each group to be understandably protective of their individual expertise. Treating the wrong patient with the wrong therapy carries risk that neither group would accept, the legal community would frown on and the insurance companies would not pay for. Recent evidence (9) seems to indicate that there may still be visual improvement if HBO 2 treatment is begun after what should be a minimal delay to establish the correct course of action. Once the patient has been referred for HBO 2, that patient is under the care of the hyperbaric physician. Whether higher, lower or a variation in atmospheric pressure results in the maximal visual improvement is unknown at this time. More is not necessarily better e.g., the platelet effect of low-dose aspirin versus higher-dose aspirin. The correct dosage is the most beneficial pressure and will be determined by further study. The hyperbaric physician, not the ophthalmologist, will make that decision. Physicians, regardless of their specialty, must work in a complementary fashion according to their training and experience to provide the patient with the best possible result. n 52
3 References 1. Murphy-Lavoie H, Butler FK, Hagan CE. Hyperbaric oxygen therapy in the management of central retinal artery occlusion. In, Gesell L, ed; Hyperbaric Oxygen Therapy Committee Report 2009; Durham; Undersea and Hyperbaric Medical Society; Rumelt S, Brown GC. Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol 2003;14(3): Feltgen N, Neubauer A, Jurklies B, et al. Multicenter study of the European assessment group for lysis in the eye (EAGLE) for the treatment of central retinal artery occlusion: Design issues and implications. EAGLE Study report no. 1. Graefe s Arch Clin Exp Ophthalmol 244: , Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125: Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3: Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18: Pfaffenbach DD, Hollenhorst RW. Morbidity and survivorship of patients with embolic cholesterol crystals in the ocular fundus. Am J Ophthalmol 1973;75: Bruno A, Jones WL, Austin JK, et al. Vascular outcome in men with asymptomatic retinal cholesterol emboli. A cohort study. Ann Intern Med 1995;122: Weiss JN. Hyperbaric oxygen treatment of nonacute central retinal artery occlusion. Undersea Hyperb Med 2009: 36;6: o 53
4 Response to Treatment of central retinal artery occlusions Heather Murphy-Lavoie 1 and Frank K. Butler 2 1 LSU School of Medicine/MCLNO, New Orleans, Lousiana, USA; 2 Military and Emergency Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA To the editor: As a practicing academic emergency medicine physician and hyperbaricist, I (along with my coauthor, Dr. Frank Butler, who has contributed to this response) am very pleased with the interest and passion exhibited from the ophthalmology community. We feel our biggest hurdle here is getting the word out there time is vision, and hyperbaric oxygen therapy (HBO 2 ) can save vision if administered before irreversible ischemia has occurred. While we understand the critical importance of making the correct diagnosis and the treatment of concomitant systemic diseases that may contribute to the development of central retinal artery occlusion (CRAO), we do not feel that treatment should be delayed to accomplish this. As little as one or two hours of delay may make the difference in whether or not the patient s vision is restored (1,3,9,10). The major differential diagnosis of acute painless vision loss includes: CRAO, central retinal vein occlusion (CRVO), vitreous hemorrhage, retinal detachment, ischemic optic neuropathies, amaurosis fugax, and posterior circulation cerebral vascular accidents (2). None of these is as crucially time-sensitive as is CRAO. Also, none of these would be harmed by HBO 2 initiated prior to an ophthalmologist s exam, and there are case reports actually showing improvement in CRVO and ischemic optic neuropathies treated with HBOT (3,4,5,6,7,8,11,12). The emergency physician is capable of differentiating CRAO from retinal detachment or vitreous hemorrhage in the majority of cases, often based on the quality of visual complaints, coupled with fundoscopic findings. Additionally, the information provided in the discussion of HBO 2 for acute painless loss of vision in the 2008 paper HBOT and the Eye, provides some suggested exclusion criteria that include: age under 40, duration of visual loss greater than 24 hours, a history or recent eye surgery or eye trauma, and a history of floaters of photopsias (3). These exclusion criteria will help to exclude many patients whose loss of vision is likely due to eye disorders that are not known to respond to HBO 2 These recommendations also call for evaluation of the patient by an ophthalmologist as soon as feasible, either before or immediately after the HBO 2. We plan to expand the discussion of systemic disease work-up for patients with CRAO in the next update of the UHMS Hyperbaric Oxygen Committee Report. We had assumed this would be done as part of basic practice in either emergency medicine or ophthalmology prior to the consultation of a hyperbaricist, but we have had a couple of requests for clarification, so we will elucidate this in the next edition. We never intended to suggest that work-up for concomitant disease was unnecessary. Thank you to Dr. Weiss and others for helping us improve communication and understanding among our specialties so that we may save vision whenever possible. n 54
5 References 1. Murphy-Lavoie H, Butler FK, and Hagan CE. Hyperbaric oxygen therapy in the management of central retinal artery occlusion. In, Gesell L, ed; Hyperbaric Oxygen Therapy Committee Report 2009; Durham; Undersea and Hyperbaric Medical Society; Beran, Dl., and Murphy-Lavoie, H. Acute, Painless Vision Loss. J La State Med Soc Jul-Aug;161(4):214-6, Butler, F.K., Hagan, C., and Murphy-Lavoie, H. Hyperbaric Oxygen Therapy and the Eye. Undersea Hyper Med Sep-Oct;35(5): Bojic, L, et al. Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone. Undersea Hyperb Med Summer;29(2): Bojic, L, et al. Hyperbaric oxygen therapy for the treatment of nonarteritic anterior ischemic optic neuropathy. Acta Med Croatica. 1995;49(3): Wright J, et al. Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen. Undersea Hyperb Med Sep- Oct;34(5): Kiryu, J and Ogura, Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica. 1996;210(3): Johnson GP. Cases from the aerospace medicine residents teaching file. Case #38. A navigator with nonischemic central retinal vein occlusion progressing to ischemic central retinal vein occlusion. Aviat Space Environ Med Oct;61(10): Beiran, I, et al. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol Oct-Dec;11(4): Hertzog LM, Meyer GW, Carson S, Strauss MB, Hart GB. Central retinal artery occlusion treated with hyperbaric oxygen. J Hyperbaric Medicine 1992;7: Beiran I, Rimon I, Weiss G, Pikkel J, Miller B. Hyperbaric oxygenation therapy for ischemic optic neuropathy. Eur J Ophthalmol 1995;5: Inoue, O, et al. Hyperbaric oxygen therapy (HBO) for central retinal vein occlusion (CRVO) short term results on seventy eyes. Undersea Hyperb Med July-Aug;35(4). o 55
Professor Helen Danesh-Meyer. Eye Institute Auckland
Professor Helen Danesh-Meyer Eye Institute Auckland Bitten by Ophthalmology Emergencies Helen Danesh-Meyer, MBChB, MD, FRANZCO Sir William and Lady Stevenson Professor of Ophthalmology Head of Glaucoma
More informationSudden Vision Loss. Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists
Sudden Vision Loss Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists My Credentials -Residency in Ophthalmology at the LSU Eye Center in New Orleans, LA -Fellowship
More informationLong-Term Evaluation of Retinal Artery Occlusion Patients Who Applied Hyperbaric Oxygen Treatment
Journal of Health Science 6 (2018) 148-152 doi: 10.17265/2328-7136/2018.03.002 D DAVID PUBLISHING Long-Term Evaluation of Retinal Artery Occlusion Patients Who Applied Savas Ilbasmis 1 and Erdinc Ercan
More informationNeuropathy (NAION) and Avastin. Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013
Non Arteritic Ischemic Optic Neuropathy (NAION) and Avastin Shalom Kelman, MD Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013 Anterior Ischemic Optic Neuropathy Acute, painless, visual loss,
More informationGrand Rounds. Eddie Apenbrinck M.D. University of Louisville School of Medicine Department of Ophthalmology & Visual Sciences 6/20/2014
Grand Rounds Eddie Apenbrinck M.D. University of Louisville School of Medicine Department of Ophthalmology & Visual Sciences 6/20/2014 Subjective CC: sudden painless loss of vision OD HPI: 75 year old
More informationHyperbaric oxygen treatment of retinal artery occlusion
Hyperbaric oxygen treatment of retinal artery occlusion Jeffrey N. Weiss Retina Associates of South Florida, Margate, Florida, USA Corresponding author: Dr. Jeffrey Weiss JWeissMD@aol.com ABSTRACT Five
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationPART 1: GENERAL RETINAL ANATOMY
PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is
More informationCHAPTER 5. Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms
CHAPTER 5 Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms Christine A.C. Wijman, Joao A. Gomes, Michael R. Winter, Behrooz Koleini, Ippolit C.A. Matjucha, Val E. Pochay, Viken L.
More informationDiabetic Retinopathy
Diabetic Retinopathy Introduction People with diabetes are more likely to have eye problems that can lead to blindness. Diabetic retinopathy is a disease of the eye s retina that is caused by diabetes.
More informationLocal Intra-arterial Fibrinolysis in Treatment of Incomplete Ophthalmic Artery Occlusion A Case Report
CASE REPORT Local Intra-arterial Fibrinolysis in Treatment of Incomplete Ophthalmic Artery Occlusion A Case Report Shih-Ting Fang, Pao-Sheng Yen 1, Chien-Chung Chen, Yuan-Chieh Lee Department of Ophthalmology,
More informationA Patient s Guide to Diabetic Retinopathy
Diabetic Retinopathy A Patient s Guide to Diabetic Retinopathy 840 Walnut Street, Philadelphia PA 19107 www.willseye.org Diabetic Retinopathy 1. Definition Diabetic retinopathy is a complication of diabetes
More informationX-Plain Diabetic Retinopathy Reference Summary
X-Plain Diabetic Retinopathy Reference Summary Introduction Patients with diabetes are more likely to have eye problems that can lead to blindness. Diabetic retinopathy is a disease of the eye s retina
More informationCase Follow Up. Sepi Jooniani PGY-1
Case Follow Up Sepi Jooniani PGY-1 Triage 54 year old M Pt presents to prelim states noticed today he had reddness to eyes, states worse in R eye. Pt denies any pain or itching. No further complaints.
More informationmeasure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control
More informationBlindness In An Elderly Woman
Blindness In An Elderly Woman A 74 y/o woman with a chief complaint of: a cloud in front of my right eye and I can t t see through it Symptoms began 24 hours prior to examination. Visual loss was painless
More informationFRANZCO, MD, MBBS. Royal Darwin Hospital
Diabetes and Eye By Dr. Nishantha Wijesinghe FRANZCO, MD, MBBS Consultant Ophthalmologist Royal Darwin Hospital 98% of Diabetics do not need to suffer from severe visual loss Yet Diabetic eye disease is
More informationHyperbaric Oxygen Therapy in two patients with Non-arteritic Anterior Optic Neuropathy who did not respond to Prednisone
Case Report Hyperbaric Oxygen Therapy in two patients with Non-arteritic Anterior Optic Neuropathy who did not respond to Prednisone L BOJIĆ, M. IVANIŠEVIĆ, G.GOŠOVIĆ Eye Clinic, Clinical Hospital Split
More informationOCCLUSIVE VASCULAR DISORDERS OF THE RETINA
OCCLUSIVE VASCULAR DISORDERS OF THE RETINA Learning outcomes By the end of this lecture the students would be able to Classify occlusive vascular disorders (OVD) of the retina. Correlate the clinical features
More informationEyes on Diabetics: How to Avoid Blindness in Diabetic Patient
Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Rova Virgana FK Unpad Pusat Mata Nasional RS Mata Cicendo Bandung Eye Center (Hospital and Clinic) PIT IDI Jabar 2018 Keys Facts from WHO
More informationFor more information about how to cite these materials visit
Author: Jonathan Trobe, MD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution 3.0 License: http://creativecommons.org/licenses/by/3.0/
More informationThe Human Eye. Cornea Iris. Pupil. Lens. Retina
The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in
More informationCourse # Flashes and Floaters and Curtains, Oh My!
Course # 132 Flashes and Floaters and Curtains, Oh My! FLASHES and FLOATERS and CURTAINS, OH MY!!! FLASHES OF LIGHT Vitreous is the villain Retinal traction Retinal hole Retinal tear Migraine Classic migraine
More informationCourse # Flashes and Floaters and Curtains, Oh My!
Course # 132 Flashes and Floaters and Curtains, Oh My! FLASHES and FLOATERS and CURTAINS, OH MY!!! FLASHES OF LIGHT Vitreous is the villain Retinal traction Retinal hole Retinal tear Migraine Classic migraine
More informationRapid Visual Loss. Dr Michael Johnson PhD FCOptom DipOrth DipGlauc DipTp(IP) Independent Prescribing Optometrist
Rapid Visual Loss Dr Michael Johnson PhD FCOptom DipOrth DipGlauc DipTp(IP) Independent Prescribing Optometrist Outline Pathophysiology Differential diagnosis. Patient scenarios in community practice:
More informationManifestations of central retinal artery occlusion revealed by fundus fluorescein angiography are associated with the degree of visual loss
2420 Manifestations of central retinal artery occlusion revealed by fundus fluorescein angiography are associated with the degree of visual loss HONGXIA GONG 1, QIUYING SONG 2 and LANHUI WANG 3 1 Department
More informationBrampton Hurontario Street Brampton, ON L6Y 0P6
Diabetic Retinopathy What is Diabetic Retinopathy Diabetic retinopathy is one of the leading causes of blindness world-wide. Diabetes damages blood vessels in many organs of the body including the eyes.
More informationAnterior Ischemic Optic Neuropathy (AION)
Anterior Ischemic Optic Neuropathy (AION) Your doctor thinks you have suffered an episode of anterior ischemic optic neuropathy (AION). This is the most common cause of sudden decreased vision in patients
More informationNeovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion
Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Man-Seong Seo,* Jae-Moon Woo* and Jeong-Jin Seo *Department of Ophthalmology, Chonnam
More informationOutline. Preventing & Treating Diabetes Related Blindness. Eye Care Center Doctors. Justin Kanoff, MD. Eye Care Center of Northern Colorado
Outline Preventing & Treating Diabetes Related Blindness Justin Kanoff, MD Eye Care Center of Northern Colorado 303 974 4302 Introduction to Eye Care Center of Northern Colorado How the eye works Eye problems
More informationCENTRAL MERSEY LOCAL OPTICAL COMMITTEE
CENTRAL MERSEY LOCAL OPTICAL COMMITTEE OPTOMETRIC REFERRAL GUIDELINES The ocular conditions listed in this document are intended to reflect those that might be encountered in optometric practice and this
More informationNIH Public Access Author Manuscript Am J Ophthalmol. Author manuscript; available in PMC 2011 March 15.
NIH Public Access Author Manuscript Published in final edited form as: Am J Ophthalmol. 2008 November ; 146(5): 631 634. doi:10.1016/j.ajo.2008.07.025. Thrombolysis for Acute Central Retinal Artery Occlusion:
More informationOPHTHALMOLOGY REFERRAL GUIDE FOR GPS
OPHTHALMOLOGY REFERRAL GUIDE FOR GPS A guidebook to support general practitioners in the management and referral of a range of common eye problems. Contents 3 Introduction 4 Ophthalmic Workup 6 Acute Visual
More informationPatient with Daily Headache NTERNATIONAL CLASSIFICATION HEADACHE DISORDERS. R. Allan Purdy, MD, FRCPC,FACP. Professor of Medicine (Neurology)
Patient with Daily Headache NTERNATIONAL CLASSIFICATION of R. Allan Purdy, MD, FRCPC,FACP HEADACHE DISORDERS Professor of Medicine (Neurology) 2nd edition (ICHD-II) Learning Issues Headaches in the elderly
More informationThe Prevalence of diabetic optic neuropathy in type 2 diabetes mellitus
The Prevalence of diabetic optic neuropathy in type 2 diabetes mellitus Received: 25/4/2016 Accepted: 8/12/2016 Introduction Diabetic papillopathy is an atypical form of non-arteritic anterior ischemic
More informationGENERAL INFORMATION DIABETIC EYE DISEASE
GENERAL INFORMATION DIABETIC EYE DISEASE WHAT IS DIABETIC EYE DISEASE? Diabetic eye disease is a term used to describe the common eye complications seen in people with diabetes. It includes: Diabetic retinopathy
More informationIncidence and Clinical Features of Neovascularization of the Iris following Acute Central Retinal Artery Occlusion
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2016;30(5):352-359 http://dx.doi.org/10.3341/kjo.2016.30.5.352 Original Article Incidence and Clinical Features of Neovascularization of the Iris following
More informationOCULAR MANIFESTATIONS OF SYSTEMIC DISEASES THUCANH MULTERER, MD
OCULAR MANIFESTATIONS OF SYSTEMIC DISEASES THUCANH MULTERER, MD UNDERGRADUATE: Philadelphia College of Pharmacy and Science 1996 MEDICAL SCHOOL: MCP Hahnemann School of Medicine, Philadelphia PA 2000 RESIDENCY:
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes mellitus is one of the leading causes of irreversible blindness worldwide. In the United States, it is the most common cause of blindness in people younger than 65 years.
More informationChris Brown, M.D. Eye Specialty Group, PLC Continuing Education Series
Chris Brown, M.D. Eye Specialty Group, PLC 2018 Continuing Education Series Disclaimer I have no financial interests in this lecture or any information discussed therein Objectives Fluorescein Angiogram
More informationDiabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?
Retinopathy Diabetes has a negative effect on eyes in many ways, increasing the risk of cataracts for example, but the most common and serious ocular complication of diabetes is retinopathy. Diabetic retinopathy
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.
More informationCHAPTER 7. Retinal Embolism: Risk Factors, Characteristics, Source and Prognosis
CHAPTER 7 Retinal Embolism: Risk Factors, Characteristics, Source and Prognosis Christine A.C. Wijman, Behrooz Koleini, Ippolit C.A. Matjucha, Ale Algra, L. Jaap Kappelle, Viken L. Babikian Submitted for
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acetazolamide, in idiopathic intracranial hypertension, 49 52, 60 Angiography, computed tomography, in cranial nerve palsy, 103 107 digital
More informationNO FINANCIAL INTERESTS ARE DISCLOSED BY THE AUTHORS
OCULAR FINDINGS IN APLASTIC ANEMIA: MULTICENTER STUDY & LITERATURE REVIEW Ahmad M Mansour1, MD, Jong Wook Lee, MD, PhD, Seung Ah Yahng, MD, Kyu Seop Kim, MD, Maha Shahin, MD, Nelson Hamerschlak, MD, PhD,
More informationSpeaker Disclosure Statement. " Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose.
Speaker Disclosure Statement Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose. Diabetes Morbidity Diabetes doubles the risk of stroke. Diabetes quadruples the risk of
More informationTitle: Clinical significance of retinal emboli during diagnostic and therapeutic cardiac catheterization
Reviewer's report Title: Clinical significance of retinal emboli during diagnostic and therapeutic cardiac catheterization Version: 1 Date: 1 September 2010 Reviewer: James Wilentz Reviewer's report: All
More informationClinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
More informationDIABETIC RETINOPATHY
DIABETIC RETINOPATHY C. L. B. Canny, MD FRCSC Diabetic retinopathy is the most serious eye manifestation of diabetes and is responsible for most of the blindness caused by diabetes. Diabetic retinopathy
More informationDiabetes & Your Eyes
Diabetes & Your Eyes Diabetes is a disease that occurs when the pancreas does not secrete enough insulin or the body is unable to process it properly. Insulin is the hormone that regulates the level of
More informationDiabetic Retinopathy A Presentation for the Public
Diabetic Retinopathy A Presentation for the Public Ray M. Balyeat, MD The Eye Institute Tulsa, Oklahoma The Healthy Eye Light rays enter the eye through the cornea, pupil and lens. These light rays are
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationRVO RETINAL VEIN OCCLUSION
RVO RETINAL VEIN OCCLUSION A guide to understanding RVO Take some time to learn about RVO - it may help you hold on to your vision Retinal vein occlusion is a common disorder of the retina and a leading
More informationDr/ Marwa Abdellah EOS /16/2018. Dr/ Marwa Abdellah EOS When do you ask Fluorescein angiography for optic disc diseases???
When do you ask Fluorescein angiography for optic disc diseases??? 1 NORMAL OPTIC DISC The normal optic disc on fluorescein angiography is fluorescent due to filling of vessels arising from the posterior
More information9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service
Temporal Arteritis Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service 1 Background Giant Cell Arteritis Temporal Arteritis Cranial Arteritis Granulomatous Arteritis
More informationSahand Ensafi PA, CCPA, B.H.Sc.,Department of Emergency Medicine, University Health Network
Sahand Ensafi PA, CCPA, B.H.Sc.,Department of Emergency Medicine, University Health Network No Disclosures Definitions Ophthalmologic Blindness Practical definition? WHO V/A less than 3/60 (snellen)
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationMild NPDR. Moderate NPDR. Severe NPDR
Diabetic retinopathy Diabetic retinopathy is the most common cause of blindness in adults aged 35-65 years-old. Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in
More informationGrand Rounds Presentation August 25, David Mostafavi MD PL2 SUNY Downstate Ophthalmology
Grand Rounds Presentation August 25, 2011 David Mostafavi MD PL2 SUNY Downstate Ophthalmology History of Present Illness 70 y/o black male with HTN c/o sudden painless vision loss right eye 9 hours prior
More informationPerspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal
Perspectives on Screening for Diabetic Retinopathy 1 Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal Current standards 2 According to the Canadian Diabetes
More informationThe Case: A 64 yo man with chronic back pain has elective multilevel lumbar spinal surgery
The Case: A 64 yo man with chronic back pain has elective multilevel lumbar spinal surgery The Case: Upon awakening from anesthesia, he is blind in both eyes After Non-Ocular Surgeries Nancy J. Newman,
More informationINTRODUCTION AND SYMPTOMS
CHAPTER 1 INTRODUCTION AND SYMPTOMS Introduction of Diabetic Retinopathy Diabetic retinopathy (DR) is a potentially blinding complication of diabetes. It is defined as presence of one or more definite
More informationObjectives. Unexplained Vision Loss: Where Do I Go From Here. History. History. Drug Induced Vision Loss
Objectives Unexplained Vision Loss: Where Do I Go From Here Denise Goodwin, OD, FAAO Coordinator, Neuro-ophthalmic Disease Clinic Pacific University College of Optometry goodwin@pacificu.edu Know the importance
More informationAnalysis of Fundus Photography and Fluorescein Angiography in Nonarteritic Anterior Ischemic Optic Neuropathy and Optic Neuritis
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2016;30(4):289-294 http://dx.doi.org/10.3341/kjo.2016.30.4.289 Original Article Analysis of Fundus Photography and Fluorescein Angiography in Nonarteritic
More informationPreliminary report on effect of retinal panphotocoagulation on rubeosis iridis and
British Journal of Ophthalmology, 1977, 61, 278-284 Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma LEILA LAATIKAINEN From Moorfields Eye Hospital,
More informationLECTURE # 7 EYECARE REVIEW: PART III
LECTURE # 7 EYECARE REVIEW: PART III HOW TO TRIAGE EYE EMERGENCIES STEVE BUTZON, O.D. EYECARE REVIEW: HOW TO TRIAGE EYE EMERGENCIES FOR PRIMARY CARE PHYSICIANS Steve Butzon, O.D. Member Director IDOC President
More informationFor details on measurement and recording of visual acuity, refer to Annex 1. VISION INTERPRETING RESULTS ABSTRACT
management update on functional decline in older adults 2012 Unit No. 5 VISION Dr Au Eong Kah Guan, Ms Yulianti, Ms Fifiana ABSTRACT Among Singaporean adults of Chinese origin aged 40 to 79 years old,
More informationPreventing blindness: Ultrasound in Giant cell arteritis
Preventing blindness: Ultrasound in Giant cell arteritis Elizabeth Jernberg, MD Associate Clinical Professor of Medicine Division of Rheumatology University of Washington Virginia Mason Medical Center
More informationPROFILE OF PATIENTS WITH FLOATERS IN SAIFUL ANWAR HOSPITAL MALANG
International Journal of Retina (IJRETINA) 2018, Volume 2, Number 1. P-ISSN. 2614-8684, E-ISSN.2614-8536 PROFILE OF PATIENTS WITH FLOATERS IN SAIFUL ANWAR HOSPITAL MALANG Fenti Kusumawardhani Hidayah,
More informationInterferon-Associated Retinopathy: Communicating with Internal Medicine Ari Wes, Esther S. Hong, MD, and Thomas A. Oetting, MS, MD
Interferon-Associated Retinopathy: Communicating with Internal Medicine Ari Wes, Esther S. Hong, MD, and Thomas A. Oetting, MS, MD July 26, 2010 Chief Complaint: New floaters in both eyes. History of Present
More informationVascular Disease Ocular Manifestations of Systemic Hypertension
Vascular Disease Ocular Manifestations of Systemic Hypertension Maynard L. Pohl, OD, FAAO Pacific Cataract & Laser Institute 10500 NE 8 th Street, Suite 1650 Bellevue, WA 98004 USA 425-462-7664 Cerebrovascular
More informationCase #1: 68 M with floaters OS
Case #1: 68 M with floaters OS Point-of-Care Ocular Sonography for the Emergency Department Nate Teismann MD Dept of Emergency Medicine, UCSF Topics in EM 2012 Acute onset of dark spots in L eye 2 days
More informationWest Los Angeles VA Health Care Center
West Los Angeles VA Health Care Center A review of the demographics of a group of general optometry patients seen recently (2015) at the main eye clinic in bldg. 304 yielded the following: Age range: 33-75
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Ophthalmic Angiography (Fluorescein and Indocyanine Green) (L34426)
Local Coverage Determination (LCD): Ophthalmic Angiography (Fluorescein and Indocyanine Green) (L34426) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website.
More informationQuestions to ponder today
Questions to ponder today What clinical signs/symptoms help me identify a retinal artery occlusion (RAO)? Past RAO? What is my responsibility to patient when I diagnose a RAO? Lab test? Imaging? If my
More informationEFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY
EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY Diwakar chaudhary *1, 2, Hu shuqiong, Long Yuan and Xiong kun 1 Yangtze University, 1 Nanhuan Road
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Ophthalmic Angiography (Fluorescein and Indocyanine Green) (L34426)
Local Coverage Determination (LCD): Ophthalmic Angiography (Fluorescein and Indocyanine Green) (L34426) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website.
More informationDiabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
Diabetic Retinopathy Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012 Outline Statistics Anatomy Categories Assessment Management Risk factors What do you need to do? Objectives Summarize the
More informationNEPTUNE RED BANK BRICK
NEPTUNE RED BANK BRICK Diabetes & The Eye Diabetics are more likely to develop Cataracts at a younger age. Diabetics are twice as likely to develop Glaucoma when compared to non-diabetics. The primary
More informationWhat Is O.C.T. and Why Should I Give A Rip? OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist 5/19/2014
OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist Email: myoder@wcoil.com Mark A. Yoder, O.D. 107 N. Main Street PO Box 123 Bluffton, OH 45817 @yoderod 115.02 Histoplasma
More informationMoncef Khairallah, MD
Moncef Khairallah, MD Department of Ophthalmology, Fattouma Bourguiba University Hospital Faculty of Medicine, University of Monastir Monastir, Tunisia INTRODUCTION IU: anatomic form of uveitis involving
More informationNeuro-Ocular Grand Rounds
Neuro-Ocular Grand Rounds Anthony B. Litwak,OD, FAAO VA Medical Center Baltimore, Maryland Dr. Litwak is on the speaker and advisory boards for Alcon and Zeiss Meditek COMMON OPTIC NEUROPATHIES THAT CAN
More information5/2/2016 EYE EMERGENCIES. Nathaniel Pelsor, O.D., FAAO Talley Medical-Surgical Eye Care Associates. Anatomy. Tools
EYE EMERGENCIES Nathaniel Pelsor, O.D., FAAO Talley Medical-Surgical Eye Care Associates Anatomy Tools 1 Contact dermatitis Blepharitis HSV Preseptal Cellulitis Anterior Chamber Subconjunctival hemorrhage
More information2009 REIMBURSEMENT GUIDE, VISUCAM and VISUCAM NM/FA
2009 REIMBURSEMENT GUIDE FF 450 PLUS PRO NM, VISUCAM and VISUCAM NM/FA Zeiss Fundus Cameras INTRODUCTION The following guide provides an overview of billing and reimbursement for procedures performed with
More informationPreparing for laser treatment for diabetic retinopathy and maculopathy
Preparing for laser treatment for diabetic retinopathy and maculopathy Information for patients Preparing for laser treatment for diabetic retinopathy and maculopathy. This leaflet sets out to answer the
More informationNeuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow
Neuropathology lecture series III. Neuropathology of Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O
More informationZEISS AngioPlex OCT Angiography. Clinical Case Reports
Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy
More informationEfficacy of early Hyperbaric Oxygen. Therapy in Central Retinal Artery Occlusion. International Journal of Clinical and Experimental Ophthalmology
Open Access International Journal of Clinical and Experimental Ophthalmology Case Report Efficacy of early Hyperbaric Oxygen ISSN 2577-140X Therapy in Central Retinal Artery Occlusion Ayse Gul Kocak Altintas*
More informationUnderstanding Diabetic Retinopathy
Understanding Diabetic Retinopathy What Is Diabetic Retinopathy? Diabetes damages blood vessels in the rear of the eye. This condition is called diabetic retinopathy. It can lead to vision loss or blindness.
More informationRafik Girgis. Consultant Ophthalmic Surgeon ( Cataract & Primary Care)
Rafik Girgis Consultant Ophthalmic Surgeon ( Cataract & Primary Care) Blepharitis Is a very common condition which usually bilateral & symmetrical. The main types are: Anterior, posterior or mixed Complications:
More informationThe use of a high-intensity laser to create an anastomotic
Case Report 866 Laser Chorioretinal Venous Anastomosis for Progressive Nonischemic Central Retinal Vein Occlusion Chih-Hsin Chen, MD; Chien-Hsiung Lai 1, MD; Hsi-Kung Kuo, MD The use of high or medium-intensity
More informationPatient Symptoms- What They Might Mean. Sarah Dougherty Wood, OD, MS, FAAO Heart of America, February 2011 Paraoptometric Lecture
Patient Symptoms- What They Might Mean Sarah Dougherty Wood, OD, MS, FAAO Heart of America, February 2011 Paraoptometric Lecture Basic ocular anatomy and physiology Movie projector analogy Blur at near/eye
More informationChamplain LHIN. Estimated that 55,563 people over age 18 live with diabetes
Champlain LHIN Estimated that 55,563 people over age 18 live with diabetes Healthy, caring communities supported by health services of choice that achieve results- today and for the future Impact of Diabetes
More informationEyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion
EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina
More information10/6/2016. HYPERTENSIVE RETINOPATHY Amiee Ho, O.D.
1 2 3 4 5 6 HYPERTENSIVE RETINOPATHY Amiee Ho, O.D. COURSE DESCRIPTION This course focuses on the clinical features, diagnosis and management of hypertensive retinopathy. Additionally, some background
More informationYear 2 MBChB Clinical Skills Session Ophthalmoscopy. Reviewed & ratified by: Mr M Batterbury Consultant Ophthalmologist
Year 2 MBChB Clinical Skills Session Ophthalmoscopy Reviewed & ratified by: o Mr M Batterbury Consultant Ophthalmologist Learning objectives o To understand the anatomy and physiology of the external and
More informationSudden loss of vision
Sudden loss of vision Abstract Du Toit N, MBChB, DipOphth(SA), FRCS(Ed), FCOphth(SA), MMed, Senior Lecturer University of Cape Town; Groote Schuur Hospital, Cape Town Correspondence to: Nagib du Toit,
More informationVITREOUS FLOATERS AND PHOTOPSIA AS PREDICTORS OF VITREORETINAL PATHOLOGY
Basrah Journal Of Surgery VITREOUS FLOATERS AND PHOTOPSIA AS PREDICTORS OF VITREORETINAL PATHOLOGY Salah Zuhair Al-Asadi MB,ChB, FRCS, FIBMS, Lecturer of Ophthalmology, College of Medicine, University
More informationUse of Orbital Color Doppler Imaging for Detecting Internal Carotid Artery Stenosis in Patients with Amaurosis Fugax
Use of Orbital Color Doppler Imaging for Detecting Internal Carotid Artery Stenosis in Patients with Amaurosis Fugax Sayuri Fujioka Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
More information